Get started
Get started

Accelerating Access, Improving Lives

Access to high-quality medicines should be equally available and affordable to everyone regardless of wealth status or geography.
Join our mission
0%

Did you know that 90% of the world’s disease burden occurs in low- and middle-income countries.We're dedicated to changing this reality by making high-quality medicines accessible and affordable for everyone.

0%

LMICs account for only 6% of global pharmaceutical sales, making them an under-served market for innovative and high-quality generic medicines

0 years

With under 7 years to meet UN Sustainable Development Goal 3, let's act now to ensure equitable access to essential medicines.

Revolutionizing Medicine Access

Explore the Axmed Medicines Platform, our groundbreaking marketplace for low- and middle-income countries. Partner with Axmed Global Health Advisory for unmatched expertise in healthcare solutions.

Stay informed, discover our innovations, and see how we’re making high-quality healthcare accessible for all.

Learn more
Green Gradient Purple Gradient

Our Solutions

Empowering patients with access to high-quality healthcare.

Axmed Medicines Platform

We use innovative technology to aggregate demand for quality medicines, ensuring patients receive the best care. By partnering with the public and private sectors, we bridge the gap between high-income markets and the needs of developing countries.

  • Ensuring equitable access to essential medicines.
  • Partnering with caregivers to improve patient outcomes.
  • Bridging global healthcare gaps with cutting-edge solutions.
Learn more

Axmed Global Health Advisory

We empower pharma companies to expand their footprint in low- and middle-income countries (LMICs). Our expert consultancy helps develop effective access strategies, ensuring more patients receive quality, affordable medicines.

  • Strategic consulting for market expansion.
  • Tailored access strategies for LMIC regions.
  • Enhancing patient access to essential medicines.
Learn more

Marketplace launch! 🚀 | October 21st!

We’re thrilled to announce the launch of our online marketplace on October 21st!

Join us on our mission of dismantling healthcare access barriers, ensuring that individuals in low- and middle-income countries have access to essential, high-quality medicines. 

Sign up now!

Martin Luther King Jr.

Insights

Axmed Wins Prestigious Norrsken Impact/100 Award, Spotlighted at Times Square

Axmed, the groundbreaking B2B marketplace revolutionizing access to essential medicines, has been honored as a 2024 Norrsken Impact/100 startup. This...

Read more
Axmed Founders: Leading the way in healthcare innovation for LMICs

Axmed raises $2 million to transform access to critical medicines in low and middle income countries

For too long, low- and middle-income countries (LMICs) have borne the brunt of global health disparities— accounting for over 80%...

Read more
Bill & Melinda Gates Foundation grant awarded to Axmed to improve access to essential medicines

Axmed Awarded $5 Million

Grant funding from the Bill & Melinda Gates Foundation targets improving access to essential medicines for the Maternal, Newborn, and...

Read more
Doctor consulting with a patient, highlighting the critical need for better access to affordable generic medicines in poor countries.

Poor countries desperately need better access to generic medicines

Manufacturers showed during the pandemic that they can deliver low-cost treatments at scale. The Covid-19 pandemic underscored the urgent need...

Read more
Children looking out a window, symbolizing hope for improved healthcare access through pooled drug procurement.

Pooled procurement of drugs in low- and middle- income countries can lower prices and improve access

Patients in the developing world often face prices for essential medicines far in excess of international reference levels, even if...

Read more
Pills held in both hands, symbolizing the newly approved Alzheimer’s disease treatment by the FDA.

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment

FDA NEWS RELEASE Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease....

Read more
Pharmacist assisting a customer in a pharmacy, reflecting the growing efforts of pharmaceutical companies to improve access to medicine

Index finds more pharma companies moving to address access to medicine. Will they now go further?

The 2022 Access to Medicine Index finds that since the COVID-19 pandemic hit, more pharmaceutical companies have stepped up to...

Read more
Two people in white hazmat suits, highlighting the resurgence of the coronavirus in America

Corona virus hits america again

Pharmaceutical companies invest heavily in R&D in order to discover and develop new drugs that can be brought to market....

Read more
Five children playing football, symbolizing the impact of drug shortages on daily life in South Africa during the COVID-19 pandemic

Drug shortages worsen in South Africa: In February 2021, it was reported that drug shortages in South Africa had worsened due to the COVID-19 pandemic

In February 2021, it was reported that drug shortages in South Africa had worsened due to a combination of factors,...

Read more

Ready to Transform Healthcare?

Join us in making quality medicines accessible for all. See how our solutions can benefit your organization and patients worldwide.

Request a demo